Almoosa Health prepares for significant growth, leveraging ipo to expand facilities, adopt cutting-edge technology, and align with Vision 2030

Almoosa Health Co. is set to revolutionize Saudi Arabia’s healthcare sector with its upcoming initial public offering (IPO), aimed at driving expansion and innovation. CEO Malek Almoosa emphasized that the IPO will raise capital to bolster the company’s services, enhance its technology infrastructure, and strengthen its market presence in the Eastern Province and beyond.

The company plans to issue 13.3 million shares, comprising 9.3 million new offerings and 4 million existing shares, representing 30 per cent of its post-IPO capital. The funds will finance ambitious projects, including the construction of two hospitals and five primary care centres, alongside investments in advanced medical technologies.

Saudi Arabia’s healthcare sector, projected to grow at a compound annual growth rate of 6.5 per cent to reach SR360 billion by 2030, provides fertile ground for Almoosa’s expansion. “The Kingdom’s healthcare infrastructure is maturing, leaving substantial room for growth and investment,” said Almoosa.

The company plans to expand its capacity to 1,430 beds across four hospitals by 2028, up from the current 730 beds. Key projects include Almoosa Specialist Hospital in Al Hofuf, slated to open in 2027 with 300 beds and 200 clinics, and a 400-bed facility in Al Khobar by 2028. Both hospitals will feature centres of excellence and advanced health IT systems.

Cornerstone investors Tawuniya and Al Fozan Holding Co. have already committed to subscribing to 6.6 per cent of the post-offering capital, reflecting strong market confidence. By listing on the Saudi Tadawul, Almoosa aims to leverage the local stock exchange’s liquidity and visibility to attract investors and align with Vision 2030’s healthcare objectives.

Beyond physical expansion, Almoosa Health prioritizes integrating cutting-edge technology to enhance operational efficiency and patient outcomes. Advanced solutions, such as Tesla 3 MRI for high-resolution imaging and automated lab systems, underscore the company’s commitment to innovation. Its facilities, including the flagship hospital in Al Ahsa, have earned accolades like HIMSS Stage 7 Accreditation for excellence in health IT.

Despite challenges like talent shortages in the region, Almoosa remains focused on attracting and retaining world-class practitioners. “Our integrated care model ensures a superior patient experience, combining pharmacy, home healthcare, and telemedicine services,” said Almoosa.

With its IPO, Almoosa Health is poised to transform healthcare in Saudi Arabia’s Eastern Province and beyond, meeting the growing demand for high-quality, integrated services.